Hong Kong Consumer Durables Stock News

SEHK:1208
SEHK:1208Metals and Mining

Assessing MMG (SEHK:1208) Valuation After Its Updated 2025 Earnings And Production Guidance

Why MMG’s latest guidance matters for shareholders MMG (SEHK:1208) has issued fresh guidance on its 2025 earnings and production plans, giving you clearer visibility on expected profitability and output across its core copper and zinc operations. The company is guiding for unaudited 2025 net profit after tax attributable to equity holders of US$500 million to US$520 million, alongside detailed volume targets at Las Bambas, Kinsevere, Khoemacau, Dugald River and Rosebery. See our latest...
SEHK:700
SEHK:700Interactive Media and Services

Assessing Tencent (SEHK:700) After Recent Share Price Pullback And Regulatory Focus

If you are wondering whether Tencent Holdings is still priced attractively after recent swings, it helps to step back and look at what the current share price might be implying about its long term value. The stock most recently closed at HK$558.0, with a 7 day return of a 10.1% decline and a 30 day return of a 10.6% decline. The return over the last year sits at 34.7% and the 3 year return at 49.6%, while the 5 year return is a 17.9% decline. Recent market attention has focused on Tencent's...
SEHK:853
SEHK:853Medical Equipment

Why MicroPort Scientific (SEHK:853) Is Down 10.2% After Guiding For A 2025 Profit Turnaround – And What's Next

In January 2026, MicroPort Scientific Corporation issued consolidated earnings guidance indicating a turnaround to profitability for 2025, forecasting a net profit of at least US$20 million versus an audited net loss of about US$268 million in 2024. This expected swing of very large magnitude in bottom-line performance highlights a significant shift in the company’s operational and financial trajectory. Next, we will examine how this anticipated return to profitability could influence...
SEHK:1672
SEHK:1672Biotechs

Ascletis Pharma (SEHK:1672) Is Up 5.4% After HK$844m Follow-On Offering And Positive Phase III Acne Data - Has The Bull Case Changed?

Ascletis Pharma recently filed a follow-on equity offering of HK$843.54 million via a subsequent direct listing, issuing 69,256,000 ordinary shares at HK$12.18 each. The fundraising follows positive Phase III data for denifanstat in moderate-to-severe acne and progress with ASC30 in metabolic disease, underscoring Ascletis’s late-stage pipeline momentum. We’ll now explore how this combination of positive Phase III acne data and a sizable equity raise shapes Ascletis Pharma’s investment...
SEHK:1211
SEHK:1211Auto

BYD (SEHK:1211) Is Down 12.5% After Fifth Straight Monthly EV Sales Drop - Has The Bull Case Changed?

In January 2026, Chinese automaker BYD reported a 30% year-on-year drop in global vehicle sales to 210,051 units, its fifth consecutive monthly decline amid reduced government incentives for electric vehicles at home and abroad. This setback comes after BYD transformed itself over two decades from a battery specialist into China’s largest automaker, with very large increases in annual vehicle sales, revenue and net income between 2020 and 2024. We’ll now examine how this abrupt sales decline...
SEHK:175
SEHK:175Auto

Assessing Geely Automobile Holdings (SEHK:175) Valuation After Polestar’s New Bank-Backed Equity Investment

Interest in Geely Automobile Holdings (SEHK:175) has picked up after its affiliate Polestar announced a US$400 million equity investment from Sumitomo Mitsui Banking Corporation and Standard Chartered Bank (Hong Kong) Limited, structured with three year put option exit rights. See our latest analysis for Geely Automobile Holdings. At a share price of HK$15.92, Geely Automobile Holdings has seen a 1-month share price return decline of 9.55% and a year-to-date share price return decline of...
SEHK:2269
SEHK:2269Life Sciences

Assessing WuXi Biologics (SEHK:2269) Valuation After New Autoimmune And Biologics Collaboration Wins

WuXi Biologics (Cayman) (SEHK:2269) has drawn fresh attention after entering into a license and research service agreement with Vertex Pharmaceuticals for trispecific T cell engagers targeting B cell mediated autoimmune diseases. See our latest analysis for WuXi Biologics (Cayman). Those fresh collaborations with Vertex, Sinorda and HanchorBio arrive as WuXi Biologics’ share price sits at HK$36.98, with a 1 month share price return of 13.64% and a 1 year total shareholder return of 87.91%...
SEHK:1483
SEHK:1483Commercial Services

Net-A-Go Technology And 2 Other Asian Penny Stocks To Watch

With recent shifts in the global economy, Asian markets have become a focal point for investors looking to navigate fluctuating conditions. Amid these developments, penny stocks—typically smaller or newer companies—remain an intriguing area of exploration for those seeking potential growth at lower price points. Despite being considered a somewhat outdated term, penny stocks continue to offer opportunities for discovering hidden value when backed by strong financials and fundamentals.
SEHK:108
SEHK:108Real Estate

Assessing GR Life Style’s Valuation As It Pursues An AI Healthcare Transformation With Mingzhi Medical

GR Life Style’s pivot toward AI healthcare GR Life Style (SEHK:108) has signed a cooperation memorandum with Mingzhi Medical Technology, aiming to link AI with oncology research and traditional Chinese medicine as it pivots away from a purely property-focused model. See our latest analysis for GR Life Style. The cooperation news comes after a sharp 32.14% 90-day share price return and a 9.75% 30-day share price return to HK$2.59. The 1-year total shareholder return of about 2.5x suggests...
SEHK:386
SEHK:386Oil and Gas

How Investors Are Reacting To China Petroleum & Chemical (SEHK:386) Tilting Toward Petrochemicals Over Fuels

China Petroleum & Chemical Corporation recently reported its 2025 operating results, showing slightly higher crude oil and natural gas production but lower refinery throughput and reduced gasoline and diesel output compared with the prior year. The company’s downstream mix shifted, with jet-fuel-related kerosene and light chemical feedstocks increasing alongside higher ethylene and synthetic resin production, highlighting a tilt toward petrochemicals. We will now examine how this shift...
SEHK:2382
SEHK:2382Electronic

Will Sunny Optical’s Strong 2025 Profit Guidance Reshape Sunny Optical Technology (Group)'s (SEHK:2382) Narrative

In January 2026, Sunny Optical Technology (Group) Company Limited issued earnings guidance for 2025, projecting profit attributable to owners of approximately RMB 4,588.6 million to RMB 4,723.5 million, compared with RMB 2,699.2 million in 2024. This very strong projected profit increase highlights management’s confidence in the company’s operating outlook and its ability to scale its core businesses. We will now examine how this very strong profit guidance shapes Sunny Optical’s investment...
SEHK:268
SEHK:268Software

Assessing Kingdee International Software Group’s Valuation As 2025 Guidance Signals Return To Profit And Double Digit Growth

Why Kingdee’s new 2025 guidance is attracting attention Kingdee International Software Group (SEHK:268) has issued earnings guidance for 2025, flagging total revenue between about CN¥6,950 million and CN¥7,050 million and an expected move from a 2024 loss to a profit. The company projects profit attributable to shareholders in the CN¥60 million to CN¥100 million range, compared with a 2024 loss of about CN¥142 million. This places both growth and profitability squarely in focus for...
SEHK:136
SEHK:136Entertainment

Does China Ruyi’s HK$2.57bn Zero-Coupon Convertible Shift Its Capital Structure Story (SEHK:136)?

China Ruyi Holdings Limited has completed a HK$2.57 billion zero-coupon, unsecured and unsubordinated convertible bond offering, maturing on January 31, 2027, under Regulation S. This zero-coupon, callable convertible structure gives China Ruyi additional funding flexibility today while creating the possibility of future equity conversion and changes to its capital structure. We’ll now examine how this sizeable zero-coupon convertible bond issuance could shape China Ruyi’s investment...
SEHK:293
SEHK:293Airlines

Did Strong 2025 Traffic Growth and Utilisation Just Shift Cathay Pacific Airways' (SEHK:293) Investment Narrative?

Cathay Pacific Airways Limited reported its December 2025 and full-year 2025 traffic results, with passenger numbers and cargo volumes both rising meaningfully versus 2024 on higher available capacity in passenger seat kilometres and freight tonne kilometres. An interesting point is that passenger growth for 2025 outpaced the increase in available seat capacity, hinting at stronger utilisation of the airline’s expanded network. We’ll now examine how this strong year-on-year growth in...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Red Envelope Push Tests AI Adoption And Regulatory Risk For Investors

Tencent Holdings (SEHK:700) is using the Lunar New Year period to promote its Yuanbao AI chatbot app with a digital red envelope campaign. The move comes as Alibaba and other Chinese tech firms increase promotional spending to attract AI users. The campaign coincides with investor concerns about possible changes to value added tax treatment for internet companies in China. Tencent, a major internet company in China with businesses spanning social media, gaming and fintech, is now putting...
SEHK:992
SEHK:992Tech

Should Lenovo’s New AI Meeting Bundles Reshape Its Enterprise Collaboration Story for Lenovo Group (SEHK:992) Investors?

Lenovo announced at ISE 2026 a new series of AI-powered full-room meeting solutions built on ThinkSmart Core Gen 2 and Huddly’s intelligent audio-video devices, offering unified management and consistent Microsoft Teams Rooms and Zoom Room experiences across different room sizes. By tightly integrating AI-optimized compute, modular multi-camera systems, and centralized device management, Lenovo is positioning its ThinkSmart-Huddly bundles as comprehensive infrastructure for more inclusive...
SEHK:1211
SEHK:1211Auto

Is BYD (SEHK:1211) Now Attractive After Recent Share Price Weakness?

Wondering if BYD at HK$91.0 is a fair entry point or if the price is out of line with its fundamentals? This article walks through that question step by step so you can judge the value for yourself. BYD's share price is currently around HK$91.0, with a 7.6% decline over the last week and a 7.8% decline over the last month, while the 1 year return sits at 0.5% and the 3 and 5 year returns are 14.6% and 12.8% respectively. Recent headlines around BYD have focused on its role in the global...